While advances have been made in NSCLC treatment due to targeted therapies and the comprehensive discovery of molecular targets such as EGFR and EML4-ALK10, 11, 12, no significant progress has been made in the treatment of SCLC over the last decade. Here, EGFR is linked to non-small cell lung carcinoma.